Advertisement
U.S. markets closed

Geratherm Medical AG (GME.DE)

XETRA - XETRA Delayed Price. Currency in EUR
4.3800+0.8800 (+25.14%)
At close: 05:36PM CET
Currency in EUR

Valuation Measures4

Market Cap (intraday) 18.94M
Enterprise Value 19.18M
Trailing P/E 18.68
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.00
Price/Book (mrq)0.89
Enterprise Value/Revenue 1.01
Enterprise Value/EBITDA 13.20

Trading Information

Stock Price History

Beta (5Y Monthly) 0.11
52-Week Change 3-36.36%
S&P500 52-Week Change 332.33%
52 Week High 35.7000
52 Week Low 32.5600
50-Day Moving Average 33.4720
200-Day Moving Average 34.1588

Share Statistics

Avg Vol (3 month) 31.03k
Avg Vol (10 day) 31.95k
Shares Outstanding 55.41M
Implied Shares Outstanding 65.49M
Float 81.53M
% Held by Insiders 170.81%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.1
Forward Annual Dividend Yield 42.86%
Trailing Annual Dividend Rate 30.10
Trailing Annual Dividend Yield 32.86%
5 Year Average Dividend Yield 43.99
Payout Ratio 472.23%
Dividend Date 3N/A
Ex-Dividend Date 4Aug 19, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -4.54%
Operating Margin (ttm)-15.59%

Management Effectiveness

Return on Assets (ttm)-0.51%
Return on Equity (ttm)-4.54%

Income Statement

Revenue (ttm)18.31M
Revenue Per Share (ttm)3.40
Quarterly Revenue Growth (yoy)-27.80%
Gross Profit (ttm)N/A
EBITDA 1.61M
Net Income Avi to Common (ttm)-830.5k
Diluted EPS (ttm)-0.1800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.33M
Total Cash Per Share (mrq)1.18
Total Debt (mrq)6.57M
Total Debt/Equity (mrq)30.76%
Current Ratio (mrq)22.02
Book Value Per Share (mrq)3.94

Cash Flow Statement

Operating Cash Flow (ttm)33k
Levered Free Cash Flow (ttm)-650.79k